A growing body of research demonstrating the association between CHIP and increased risks of hematologic cancer and cardiovascular disease supports further investigation into mechanisms, causality, and novel treatment strategies to improve clinical outcomes. The gene discussed is STUB1; the disease is cardiovascular disorder.